HIV integrase inhibitors
US6541515B2 · kind B2 · utility
4Cited by
9References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2001 |
| Grant date | Apr 1, 2003 |
| Priority date | — |
| Expiry date | Aug 9, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/28
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines are described. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. The culture Cytospora sp. MF 6608 (ATCC PTA-1691) is also disclosed, as well as processes for making a compound of the present invention employing the culture.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.